Overview
My research efforts have been focused on identifying prognostic and therapeutic biomarkers in B-cell lymphoma. My research interests also include investigation of molecular and immune mechanisms underlying the poor clinical outcomes of lymphoma, the pathogenesis and evolution of drug resistant clones, and development of novel therapies for aggressive B-cell lymphoma.
Current Duke Appointments & Affiliations
Assistant Professor in Pathology
·
2021 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2019 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
Grading of Castleman Disease Histopathology with an Attention-Based Multiple Instance Learning Model.
Journal article Diagnostics (Basel) · August 27, 2026 Background/Objectives: Castleman disease is a rare cytokine-driven lymphoproliferative disorder in which lymph node histopathology provides key diagnostic information. Morphologic features are graded semiquantitatively and often show substantial interobser ... Full text Link to item CiteApplication of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.
Journal article Blood Adv · June 16, 2026 Diffuse large B-cell lymphoma (DLBCL), the most common type of lymphoma, arises from various pathogenic mechanisms including gene translocations and fusions. Detection of gene rearrangements using fluorescence in situ hybridization (FISH) is a standard pra ... Full text Link to item CiteAbstract 4661: Expression of the ferroptosis suppressor FSP1 but not GPX4 shows significant adverse prognostic effect in diffuse large B-cell lymphoma with wild-type TP53
Conference Cancer Research · April 3, 2026 AbstractIntroduction:Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma. Previous studies have ... Full text CiteRecent Grants
PD-L1 Modifications in Cancer Diagnosis and Treatment
ResearchCo Investigator · Awarded by Baylor College of Medicine · 2025 - 2030Spatially resolved, single cell biomarkers of B cell lymphoma
ResearchCo Investigator · Awarded by Cedars Sinai Medical Center · 2022 - 2027Genetic and Epigenetic Biomarkers for B-cell Lymphoma
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025View All Grants
Education
Michigan Technological University ·
2009
Ph.D.